Accept Refuse

EUR-Lex Search results

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Search Results

Domain: All, Subdomain: All documents, Documents mentioning: 31991L0356, Search language: English
2

Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use

OJ L 121, 1.5.2001, p. 34–44 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
This document has been published in a special edition(s) (CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO, HR)

In force

CELEX number:
32001L0020
Author:
European Parliament, Council of the European Union
Date of document:
04/04/2001

Decision of the EEA Joint Committee No 23/2004 of 19 March 2004 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

OJ L 127, 29.4.2004, p. 128–129 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
This document has been published in a special edition(s) (CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO, HR)

In force

CELEX number:
22004D0023
Author:
EEA Joint Committee
Date of document:
19/03/2004

Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use

OJ L 136, 30.4.2004, p. 85–90 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
This document has been published in a special edition(s) (CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO, HR)

In force

CELEX number:
32004L0024
Author:
European Parliament, Council of the European Union
Date of document:
31/03/2004

Commission Directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use (Text with EEA relevance)

OJ L 262, 14.10.2003, p. 22–26 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
This document has been published in a special edition(s) (CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO, HR)

In force

CELEX number:
32003L0094
Author:
European Commission
Date of document:
08/10/2003

Agreement on mutual recognition between the European Community and Japan - Annexes - Final Act - Joint Declarations - Exchange of letters

OJ L 284, 29.10.2001, p. 3–32 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
This document has been published in a special edition(s) (CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO, HR)

In force

CELEX number:
22001A1029(01)
Author:
European Community, Japan
Date of document:
04/04/2001

WRITTEN QUESTION No. 2335/96 by Hiltrud BREYER to the Commission. BSE and medicinal products

OJ C 83, 14.3.1997, p. 10 (ES, DA, DE, EL, EN, FR, IT, NL, PT)

CELEX number:
91996E002335
Author:
European Parliament, BREYER
Date of document:
27/08/1996; Date of transmission

WRITTEN QUESTION No. 3537/93 by Alexandros ALAVANOS to the Commission. Blood and blood products contaminated with the AIDS virus

OJ C 340, 5.12.1994, p. 41 (ES, DA, DE, EL, EN, FR, IT, NL, PT)

CELEX number:
91993E003537
Author:
European Parliament, ALAVANOS
Date of document:
13/12/1993; Date of transmission
2